| scholarly article | Q13442814 |
| P2093 | author name string | Laura F Gibson | |
| Scot C Remick | |||
| Soumit K Basu | |||
| Manish Monga | |||
| P2860 | cites work | Leptomeningeal metastasis | Q84680089 |
| Relevance of CD6-mediated interactions in T cell activation and proliferation | Q24300571 | ||
| Genes that mediate breast cancer metastasis to the brain | Q24644008 | ||
| Ph+/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells | Q24650730 | ||
| Thirty years of prophylactic cranial irradiation in patients with small cell lung cancer: a meta-analysis of randomized clinical trials | Q26864158 | ||
| The vascular basement membrane as "soil" in brain metastasis | Q27348725 | ||
| Mutations in isocitrate dehydrogenase 2 accelerate glioma cell migration via matrix metalloproteinase-2 and 9 | Q28572144 | ||
| The blood-brain barrier in health and chronic neurodegenerative disorders | Q29616411 | ||
| Real-time imaging reveals the single steps of brain metastasis formation | Q33519908 | ||
| Central nervous system disease in hematologic malignancies: historical perspective and practical applications | Q33585849 | ||
| Leukocyte traffic in the central nervous system: the participants and their roles | Q33636045 | ||
| Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins | Q33998763 | ||
| Blood-brain barrier delivery | Q34001715 | ||
| Reactive Astrocytes Protect Melanoma Cells from Chemotherapy by Sequestering Intracellular Calcium through Gap Junction Communication Channels | Q34105366 | ||
| Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. | Q34192343 | ||
| Angiotensin II facilitates breast cancer cell migration and metastasis | Q34247434 | ||
| Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier | Q34446031 | ||
| Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells | Q34452930 | ||
| Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences | Q34608061 | ||
| Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. | Q34618411 | ||
| First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial | Q34629920 | ||
| Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. | Q34666837 | ||
| Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis | Q34666843 | ||
| Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. | Q34744928 | ||
| Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma | Q35064709 | ||
| Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer. | Q35119038 | ||
| Three or more routes for leukocyte migration into the central nervous system | Q35183162 | ||
| Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses | Q35402351 | ||
| Integrin β4 signaling promotes mammary tumor cell adhesion to brain microvascular endothelium by inducing ErbB2-mediated secretion of VEGF. | Q35525904 | ||
| The management of brain metastases | Q35571251 | ||
| Involvement of the central nervous system in malignant lymphomas | Q43423784 | ||
| Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells | Q43727826 | ||
| CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia | Q43991377 | ||
| Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model | Q44101945 | ||
| Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia | Q44536202 | ||
| The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia | Q44632827 | ||
| CNS involvement in mantle-cell lymphoma. | Q44672222 | ||
| The soluble VEGF receptor 1 and 2 expression in cerebral spinal fluid as an indicator for leukemia central nervous system metastasis | Q45161318 | ||
| Expression and significance of vascular endothelial growth factor A and C in leukemia central nervous system metastasis | Q45344387 | ||
| CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. | Q45420445 | ||
| Primary breast lymphoma: results of a controlled clinical trial. | Q46706562 | ||
| Increased angiogenesis-associated poor outcome in acute lymphoblastic leukemia: a single center study | Q48021180 | ||
| Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer | Q48371008 | ||
| Survival of brain metastatic patients treated with gamma knife radiosurgery alone | Q48470558 | ||
| Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation | Q48480145 | ||
| Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias. | Q52575669 | ||
| Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia? | Q52608952 | ||
| Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis. | Q52832387 | ||
| Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis? | Q53271209 | ||
| Prognostic significance of VEGF, VEGF receptors and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy | Q60254207 | ||
| Adult central nervous system leukemia: incidence and clinicopathologic features | Q67525887 | ||
| Distribution of brain metastases | Q68430762 | ||
| CD117/CD34 expression in leukemic blasts | Q71270613 | ||
| Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group | Q78729026 | ||
| Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment | Q80296215 | ||
| Survival in patients with brain metastases from breast cancer: the importance of HER-2 status | Q80940181 | ||
| Lung cancer and its operable brain metastasis: survival rate and staging problems | Q81202478 | ||
| [Expression of CD56, as a potential diagnostic marker, in small cell carcinoma] | Q81207306 | ||
| MCP-1 in the cerebrospinal fluid of children with acute lymphoblastic leukemia | Q82726146 | ||
| Vascular endothelial growth factor-C and its receptor type-3 expressed in acute lymphocytic leukemia cases with t(1;19) | Q84510963 | ||
| CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact | Q35589008 | ||
| The biology of brain metastases-translation to new therapies | Q35676602 | ||
| Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis | Q35787684 | ||
| Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993 | Q35848955 | ||
| The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications | Q35912178 | ||
| Brain metastases: epidemiology and pathophysiology. | Q36282137 | ||
| Matrix metalloproteinases: changing roles in tumor progression and metastasis | Q36422976 | ||
| Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer | Q36625206 | ||
| Treatment of adult acute lymphoblastic leukemia | Q36662137 | ||
| Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment | Q36662139 | ||
| Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. | Q36922699 | ||
| Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model | Q37053185 | ||
| Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia | Q37071108 | ||
| Current management and challenges of malignant disease in the CNS in paediatric leukaemia | Q37097413 | ||
| VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown | Q37100939 | ||
| CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia | Q37113435 | ||
| The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance | Q37152481 | ||
| Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. | Q37234638 | ||
| Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment. | Q37280933 | ||
| Treatment and prevention of secondary CNS lymphoma | Q37767641 | ||
| The role of the organ microenvironment in brain metastasis | Q37822088 | ||
| Extracellular proteolysis in macrophage migration: losing grip for a breakthrough | Q37939732 | ||
| Epidemiology of central nervous system metastases. | Q37975016 | ||
| Pathological roles of invadopodia in cancer invasion and metastasis | Q38015601 | ||
| Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival | Q38019011 | ||
| Targeted therapy in brain metastasis | Q38028295 | ||
| EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small-cell lung cancer | Q38068204 | ||
| Invadopodia and rolling-type motility are specific features of highly invasive p190(bcr-abl) leukemic cells. | Q39327944 | ||
| Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis. | Q39363169 | ||
| Human brain endothelial cell-derived COX-2 facilitates extravasation of breast cancer cells across the blood-brain barrier | Q39422158 | ||
| Induction of vascular endothelial growth factor secretion by childhood acute lymphoblastic leukemia cells via the FLT-3 signaling pathway. | Q39442922 | ||
| Cellular elements of the subarachnoid space promote ALL survival during chemotherapy | Q39602322 | ||
| VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers | Q39703856 | ||
| Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia | Q40059658 | ||
| Blood-brain barrier-specific properties of a human adult brain endothelial cell line | Q40377619 | ||
| The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma | Q40490061 | ||
| Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). | Q40812940 | ||
| Cellular invasion into matrix beads: localization of beta 1 integrins and fibronectin to the invadopodia | Q41681739 | ||
| Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. | Q43022293 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 257-267 | |
| P577 | publication date | 2013-12-05 | |
| P1433 | published in | Clinical & Experimental Metastasis | Q13470030 |
| P1476 | title | Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies | |
| P478 | volume | 31 |
| Q38791976 | Adapting coculture in vitro models of the blood-brain barrier for use in cancer research: maintaining an appropriate endothelial monolayer for the assessment of transendothelial migration. |
| Q91737787 | Biomarkers Reflecting The Destruction Of The Blood-Brain Barrier Are Valuable In Predicting The Risk Of Lymphomas With Central Nervous System Involvement |
| Q38936718 | Cancer Seeding Risk from an Epidural Blood Patch in Patients with Leukemia or Lymphoma |
| Q37023412 | Ophthalmic Manifestations of Hematopoietic Malignancy. |
| Q41513151 | The prognostic significance of serum and cerebrospinal fluid MMP-9, CCL2 and sVCAM-1 in leukemia CNS metastasis |
| Q50325439 | The role of cytokines and chemokines in the microenvironment of the blood-brain barrier in leukemia central nervous system metastasis |
Search more.